The transcriptional regulator peroxisome proliferator activated receptor gamma coactivator 1A (PGC-1α), encoded by PPARGC1A, has been linked to neurodegenerative diseases. Recently discovered CNS-specific PPARGC1A transcripts are initiated far upstream of the reference promoter, spliced to exon 2 of the reference gene, and are more abundant than reference gene transcripts in post-mortem human brain samples. The proteins translated from the CNS and reference transcripts differ only at their N-terminal regions. To dissect functional differences between CNS-specific isoforms and reference proteins, we used clustered regularly interspaced short palindromic repeats transcriptional activation (CRISPRa) for selective endogenous activation of the CNS or the reference promoters in SH-SY5Y cells. Expression and/or exon usage of the targets was ascertained by RNA sequencing. Compared to controls, more differentially expressed genes were observed after activation of the CNS than the reference gene promoter, while the magnitude of alternative exon usage was comparable between activation of the two promoters. Promoter-selective associations were observed with canonical signaling pathways, mitochondrial and nervous system functions and neurological diseases. The distinct N-terminal as well as the shared downstream regions of PGC-1α isoforms affect the exon usage of numerous genes. Furthermore, associations of risk genes of amyotrophic lateral sclerosis and Parkinson's disease were noted with differentially expressed genes resulting from the activation of the CNS and reference gene promoter, respectively. Thus, CNS-specific isoforms markedly amplify the biological functions of PPARGC1A and CNS-specific isoforms and reference proteins have common, complementary and selective functions relevant for neurodegenerative diseases.

3rd Medical Department Cancer Research Institute Paracelsus Medical University Cancer Cluster Salzburg 5020 Salzburg Austria

CEITEC Central European Institute of Technology Masaryk University Kamenice 5 62500 Brno Czech Republic

Department of Pathology and Laboratory Medicine Perlman School of Medicine University of Pennsylvania 614 Stellar Chance Labs 422 Curie Blvd Philadelphia PA 19104 6100 USA

Department of Personalized Medicine Humanomed 9020 Klagenfurt Austria

Division of Neuropathology Neuromed Campus Kepler University Hospital 4020 Linz Austria

EB House Austria Research Program for Molecular Therapy of Genodermatoses Department of Dermatology and Allergology University Hospital of the Paracelsus Medical University 5020 Salzburg Austria

Institute of Pharmacology and Toxicology Paracelsus Medical University Strubergasse 18 5020 Salzburg Austria

PharmGenetix GmbH 5081 Niederalm Austria

See more in PubMed

Wang E.T., Sandberg R., Luo S., Khrebtukova I., Zhang L., Mayr C., Kingsmore S.F., Schroth G.P., Burge C.B. Alternative isoform regulation in human tissue transcriptomes. Nature. 2008;456:470–476. doi: 10.1038/nature07509. PubMed DOI PMC

Nilsen T.W., Graveley B.R. Expansion of the eukaryotic proteome by alternative splicing. Nature. 2010;463:457–463. doi: 10.1038/nature08909. PubMed DOI PMC

Carninci P., Kasukawa T., Katayama S., Gough J., Frith M.C., Maeda N., Oyama R., Ravasi T., Lenhard B., Wells C., et al. The transcriptional landscape of the mammalian genome. Science. 2005;309:1559–1563. PubMed

Lin J., Handschin C., Spiegelman B.M. Metabolic control through the PGC-1 family of transcription coactivators. Cell Metab. 2005;1:361–370. doi: 10.1016/j.cmet.2005.05.004. PubMed DOI

Vega R.B., Kelly D.P. Cardiac nuclear receptors: Architects of mitochondrial structure and function. J. Clin. Investig. 2017;127:1155–1164. doi: 10.1172/JCI88888. PubMed DOI PMC

Soyal S., Krempler F., Oberkofler H., Patsch W. PGC-1α: A potent transcriptional cofactor involved in the pathogenesis of type 2 diabetes. Diabetologia. 2006;49:1477–1488. doi: 10.1007/s00125-006-0268-6. PubMed DOI

Monsalve M., Wu Z., Adelmant G., Puigserver P., Fan M., Spiegelman B.M. Direct Coupling of Transcription and mRNA Processing through the Thermogenic Coactivator PGC-1. Mol. Cell. 2000;6:307–316. doi: 10.1016/S1097-2765(00)00031-9. PubMed DOI

Zhang Y., Huypens P., Adamson A.W., Chang J.S., Henagan T.M., Boudreau A., Lenard N.R., Burk D., Klein J., Perwitz N., et al. Alternative mRNA Splicing Produces a Novel Biologically Active Short Isoform of PGC-1α. J. Biol. Chem. 2009;284:32813–32826. doi: 10.1074/jbc.M109.037556. PubMed DOI PMC

Ruas J.L., White J.P., Rao R.R., Kleiner S., Brannan K.T., Harrison B.C., Greene N.P., Wu J., Estall J.L., Irving B.A., et al. A PGC-1α Isoform Induced by Resistance Training Regulates Skeletal Muscle Hypertrophy. Cell. 2012;151:1319–1331. doi: 10.1016/j.cell.2012.10.050. PubMed DOI PMC

Soyal S.M., Felder T.K., Auer S., Hahne P., Oberkofler H., Witting A., Paulmichl M., Landwehrmeyer G.B., Weydt P., Patsch W. A greatly extended PPARGC1A genomic locus encodes several new brain-specific isoforms and influences Huntington disease age of onset†. Hum. Mol. Genet. 2012;21:3461–3473. doi: 10.1093/hmg/dds177. PubMed DOI

Miura S., Kai Y., Kamei Y., Ezaki O. Isoform-specific increases in murine skeletal muscle peroxisome proliferator-activated receptor-gamma coactivator-1alpha (PGC-1alpha) mRNA in response to beta2-adrenergic receptor activation and exercise. Endocrinology. 2008;149:4527–4533. doi: 10.1210/en.2008-0466. PubMed DOI

Tadaishi M., Miura S., Kai Y., Kano Y., Oishi Y., Ezaki O. Skeletal Muscle-Specific Expression of PGC-1α-b, an Exercise-Responsive Isoform, Increases Exercise Capacity and Peak Oxygen Uptake. PLoS ONE. 2011;6:e28290. doi: 10.1371/journal.pone.0028290. PubMed DOI PMC

Esterbauer H., Oberkofler H., Krempler F., Patsch W. Human peroxisome proliferator activated receptor gamma coactivator 1 (PPARGC1) gene: cDNA sequence, genomic organization, chromosomal localization, and tissue expression. Genomics. 1999;62:98–102. doi: 10.1006/geno.1999.5977. PubMed DOI

Felder T.K., Soyal S.M., Oberkofler H., Hahne P., Auer S., Weiss R., Gadermaier G., Miller K., Krempler F., Esterbauer H., et al. Characterization of novel peroxisome proliferator-activated receptor gamma coactivator-1alpha (PGC-1alpha) isoform in human liver. J. Biol. Chem. 2011;286:42923–42936. doi: 10.1074/jbc.M111.227496. PubMed DOI PMC

Cui L., Jeong H., Borovecki F., Parkhurst C.N., Tanese N., Krainc D. Transcriptional repression of PGC-1alpha by mutant huntingtin leads to mitochondrial dysfunction and neurodegeneration. Cell. 2006;127:59–69. doi: 10.1016/j.cell.2006.09.015. PubMed DOI

Weydt P., Pineda V.V., Torrence A.E., Libby R.T., Satterfield T.F., Lazarowski E.R., Gilbert M.L., Morton G.J., Bammler T.K., Strand A.D., et al. Thermoregulatory and metabolic defects in Huntington’s disease transgenic mice implicate PGC-1alpha in Huntington’s disease neurodegeneration. Cell Metab. 2006;4:349–362. doi: 10.1016/j.cmet.2006.10.004. PubMed DOI

Shin J.H., Ko H.S., Kang H., Lee Y., Lee Y.I., Pletinkova O., Troconso J.C., Dawson V.L., Dawson T.M. PARIS (ZNF746) repression of PGC-1alpha contributes to neurodegeneration in Parkinson’s disease. Cell. 2011;144:689–702. doi: 10.1016/j.cell.2011.02.010. PubMed DOI PMC

Katsouri L., Lim Y.M., Blondrath K., Eleftheriadou I., Lombardero L., Birch A.M., Mirzaei N., Irvine E.E., Mazarakis N.D., Sastre M. PPARgamma-coactivator-1alpha gene transfer reduces neuronal loss and amyloid-beta generation by reducing beta-secretase in an Alzheimer’s disease model. Proc. Natl. Acad. Sci. USA. 2016;113:12292–12297. doi: 10.1073/pnas.1606171113. PubMed DOI PMC

Zhao W., Varghese M., Yemul S., Pan Y., Cheng A., Marano P., Hassan S., Vempati P., Chen F., Qian X., et al. Peroxisome proliferator activator receptor gamma coactivator-1alpha (PGC-1alpha) improves motor performance and survival in a mouse model of amyotrophic lateral sclerosis. Mol. Neurodegener. 2011;6:51. doi: 10.1186/1750-1326-6-51. PubMed DOI PMC

Witte M.E., Nijland P.G., Drexhage J.A.R., Gerritsen W., Geerts D., van Het B.H., Reijerkerk A., de Vries H.E., van Horssen J. Reduced expression of PGC-1alpha partly underlies mitochondrial changes and correlates with neuronal loss in multiple sclerosis cortex. Acta Neuropathol. 2013;125:231–243. doi: 10.1007/s00401-012-1052-y. PubMed DOI

Nijland P.G., E Witte M., Hof B.V.H., Van Der Pol S., Bauer J.S., Lassmann H., van der Vries H.E., van Horssen J. Astroglial PGC-1alpha increases mitochondrial antioxidant capacity and suppresses inflammation: Implications for multiple sclerosis. Acta Neuropathol. Commun. 2014;2:170. doi: 10.1186/s40478-014-0170-2. PubMed DOI PMC

Baker E., Sims R., Leonenko G., Frizzati A., Harwood J.C., Grozeva D., Morgan K., Passmore P., Holmes C., Powell J., et al. Gene-based analysis in HRC imputed genome wide association data identifies three novel genes for Alzheimer’s disease. PLoS ONE. 2019;14:e0218111. PubMed PMC

Soyal S.M., Zara G., Ferger B., Felder T.K., Kwik M., Nofziger C., Dossena S., Schwienbacher C., Hicks A.A., Pramstaller P.P., et al. The PPARGC1A locus and CNS-specific PGC-1alpha isoforms are associated with Parkinson’s Disease. Neurobiol. Dis. 2019;121:34–46. doi: 10.1016/j.nbd.2018.09.016. PubMed DOI

Weydt P., Soyal S.M., Landwehrmeyer G.B., Patsch W. A single nucleotide polymorphism in the coding region of PGC-1alpha is a male-specific modifier of Huntington disease age-at-onset in a large European cohort. BMC Neurol. 2014;14:1. doi: 10.1186/1471-2377-14-1. PubMed DOI PMC

Che H.V., Metzger S., Portal E., Deyle C., Riess O., Nguyen H.P. Localization of sequence variations in PGC-1alpha influence their modifying effect in Huntington disease. Mol. Neurodegener. 2011;6:1. doi: 10.1186/1750-1326-6-1. PubMed DOI PMC

Zheng B., Liao Z., Locascio J.J., Lesniak K.A., Roderick S.S., Watt M.L., Eklund A.C., Zhang-James Y., Kim P.D., Hauser M.A., et al. PGC-1alpha, a potential therapeutic target for early intervention in Parkinson’s disease. Sci. Transl. Med. 2010;2:52ra73. doi: 10.1126/scitranslmed.3001059. PubMed DOI PMC

Clark J., Reddy S., Zheng K., Betensky R.A., Simon D.K. Association of PGC-1alpha polymorphisms with age of onset and risk of Parkinson’s disease. BMC Med. Genet. 2011;12:69. doi: 10.1186/1471-2350-12-69. PubMed DOI PMC

Eschbach J., Schwalenstöcker B., Soyal S.M., Bayer H., Wiesner D., Akimoto C., Nilsson A.C., Birve A., Meyer T., Dupuis L., et al. PGC-1alpha is a male-specific disease modifier of human and experimental amyotrophic lateral sclerosis. Hum. Mol. Genet. 2013;22:3477–3484. doi: 10.1093/hmg/ddt202. PubMed DOI

Soyal S.M., Bonova P., Kwik M., Zara G., Auer S., Scharler C., Strunk D., Nofziger C., Paulmichl M., Patsch W. The Expression of CNS-Specific PPARGC1A Transcripts Is Regulated by Hypoxia and a Variable GT Repeat Polymorphism. Mol. Neurobiol. 2020;57:752–764. doi: 10.1007/s12035-019-01731-5. PubMed DOI PMC

Jinek M., Chylinski K., Fonfara I., Hauer M., Doudna J.A., Charpentier E. A programmable dual-RNA-guided DNA endonuclease in adaptive bacterial immunity. Science. 2012;337:816–821. doi: 10.1126/science.1225829. PubMed DOI PMC

Gilbert L.A., Horlbeck M.A., Adamson B., Villalta J.E., Chen Y., Whitehead E.H., Guimaraes C., Panning B., Ploegh H.L., Bassik M.C., et al. Genome-Scale CRISPR-Mediated Control of Gene Repression and Activation. Cell. 2014;159:647–661. doi: 10.1016/j.cell.2014.09.029. PubMed DOI PMC

Konermann S., Brigham M.D., Trevino A.E., Joung J., Abudayyeh O.O., Barcena C., Hsu P.D., Habib N., Gootenberg J.S., Nishimasu H., et al. Genome-scale transcriptional activation by an engineered CRISPR-Cas9 complex. Nature. 2015;517:583–588. doi: 10.1038/nature14136. PubMed DOI PMC

Chavez A., Scheiman J., Vora S.D., Pruitt B.W., Tuttle M., Iyer P.R., Lin S., Kiani S., Guzman C.D., Wiegand D.J., et al. Highly efficient Cas9-mediated transcriptional programming. Nat. Methods. 2015;12:326–328. doi: 10.1038/nmeth.3312. PubMed DOI PMC

Galganski L., Urbanek M.O., Krzyzosiak W.J. Nuclear speckles: Molecular organization, biological function and role in disease. Nucleic Acids Res. 2017;45:10350–10368. doi: 10.1093/nar/gkx759. PubMed DOI PMC

Liu Y., Beyer A., Aebersold R. On the Dependency of Cellular Protein Levels on mRNA Abundance. Cell. 2016;165:535–550. doi: 10.1016/j.cell.2016.03.014. PubMed DOI

Szklarczyk D., Gable A.L., Nastou K.C., Lyon D., Kirsch R., Pyysalo S., Doncheva N.T., Legeay M., Fang T., Borket P., et al. The STRING database in 2021: Customizable protein-protein networks, and functional characterization of user-uploaded gene/measurement set. Nucleic Acids Res. 2021;49:D605–D612. doi: 10.1093/nar/gkaa1074. PubMed DOI PMC

Ross C.A., Aylward E.H., Wild E.J., Langbehn D.R., Long J.D., Warner J.H., Scahill R.I., Leavitt B.R., Stout J.C., Paulsen J.S., et al. Huntington disease: Natural history, biomarkers and prospects for therapeutics. Nat. Rev. Neurol. 2014;10:204–216. doi: 10.1038/nrneurol.2014.24. PubMed DOI

Dervishi I., Gozutok O., Murnan K., Gautam M., Heller D., Bigio E., Ozdinler P.H. Protein-protein interactions reveal key canonical pathways, upstream regulators, interactome domains, and novel targets in ALS. Sci. Rep. 2018;8:14732. doi: 10.1038/s41598-018-32902-4. PubMed DOI PMC

Mejzini R., Flynn L.L., Pitout I.L., Fletcher S., Wilton S.D., Akkari P.A. ALS Genetics, Mechanisms, and Therapeutics: Where Are We Now? Front. Neurosci. 2019;13:1310. PubMed PMC

van Reen W., Shatunov A., Dekker A.M., McLaughlin R.L., Diekstra F.P., Pulit S.L., van der Spek R.A., Vosa U., de Jong S., Robinson M.R., et al. Genome-wide association analyses identify new risk variants and the genetic architecture of amyotrophic lateral sclerosis. Nat. Genet. 2016;48:1043–1048. doi: 10.1038/ng.3622. PubMed DOI PMC

Wei L., Tian Y., Chen Y., Wie Q., Chen F., Cao B., Wu Y., Zhao B., Chen X., Xie C., et al. Identification of TYW3/CRYZ and FGD4 as susceptibility genes for amyotrophic lateral sclerosis. Neurol. Genet. 2019;5:e375. doi: 10.1212/NXG.0000000000000375. PubMed DOI PMC

Klim J.R., Williams L.A., Limone F., Guerra S.J., Davis-Dusenbery B.N., Mordes D.A., Burberry A., Steinbaugh M.J., Gamage K.K., Kirchner R., et al. ALS-implicated protein TDP-43 sustains levels of STMN2, a mediator of motor neuron growth and repair. Nat. Neurosci. 2019;22:167–179. doi: 10.1038/s41593-018-0300-4. PubMed DOI PMC

Krishna A., Biryukov M., Trefois C., Antony P.M., Hussong R., Lin J., Heinaniemi M., Glusman G., Koglsberger S., Boyd O., et al. Systems genomics evaluation of the SH-SY5Y neuroblastoma cell line as a model for Parkinson’s disease. BMC Genomics. 2014;15:1154. doi: 10.1186/1471-2164-15-1154. PubMed DOI PMC

Kunkle B.W., Grenier-Boley B., Sims R., Bis J.C., Damotte V., Naj A.C., Boland A., Vronskaya M., van der Lee S.J., Amlie-Wolf A., et al. Genetic meta-analysis of diagnosed Alzheimer’s disease identifies new risk loci and implicates Abeta, tau, immunity and lipid processing. Nat. Genet. 2019;51:414–430. doi: 10.1038/s41588-019-0358-2. PubMed DOI PMC

Jansen I.E., Savage J.E., Watanabe K., Bryois J., Williams D.M., Steinberg S., Sealock J., Karlsson I.K., Hagg S., Athanasiu L., et al. Genome-wide meta-analysis identifies new loci and functional pathways influencing Alzheimer’s disease risk. Nat. Genet. 2019;51:404–413. doi: 10.1038/s41588-018-0311-9. PubMed DOI PMC

Sims R., Hill M., Williams J. The multiplex model of the genetics of Alzheimer’s disease. Nat. Neurosci. 2020;23:311–322. doi: 10.1038/s41593-020-0599-5. PubMed DOI

Nalls M.A., Blauwendraat C., Vallerga C.L., Heilbron K., Bandres-Ciga S., Chang D., Tan M., Kia D.A., Noyce A.J., Xue A., et al. Identification of novel risk loci, causal insights, and heritable risk for Parkinson’s disease: A meta-analysis of genome-wide association studies. Lancet Neurol. 2019;18:1091–1102. doi: 10.1016/S1474-4422(19)30320-5. PubMed DOI PMC

Billingsley K.J., Bandres-Ciga S., Saez-Atienzar S., Singleton A.B. Genetic risk factors in Parkinson’s disease. Cell Tissue Res. 2018;373:9–20. doi: 10.1007/s00441-018-2817-y. PubMed DOI PMC

Genetics Home Reference. NIH. [(accessed on 16 March 2020)]; Available online: https://ghr.nlm.nih.gov/condition/parkinson-disease#resources.

Martinez-Redondo V., Jannig P.R., Correia J.C., Ferreira D.M., Cervenka I., Lindvall J.M., Sinha I., Izadi M., Pettersson-Klein A.T., Agudelo L.Z., et al. Peroxisome Proliferator-activated Receptor gamma Coactivator-1 alpha Isoforms Selectively Regulate Multiple Splicing Events on Target Genes. J. Biol. Chem. 2016;291:15169–15184. doi: 10.1074/jbc.M115.705822. PubMed DOI PMC

Anders S., Reyes A., Huber W. Detecting differential usage of exons from RNA-seq data. Genome Res. 2012;22:2008–2017. doi: 10.1101/gr.133744.111. PubMed DOI PMC

Fecto F., Yan J., Vemula S.P., Liu E., Yang Y., Chen W., Zheng J.G., Shi Y., Siddique N., Arrat H., et al. SQSTM1 mutations in familial and sporadic amyotrophic lateral sclerosis. Arch. Neurol. 2011;68:1440–1446. doi: 10.1001/archneurol.2011.250. PubMed DOI

Rubino E., Rainero I., Chio A., Rogaeva E., Galimberti D., Fenoglio P., Grinberg Y., Isaia G., Calvo A., Gentile S., et al. SQSTM1 mutations in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Neurology. 2012;79:1556–1562. doi: 10.1212/WNL.0b013e31826e25df. PubMed DOI PMC

Thom R., Rowe G.C., Jang C., Safdar A., Arany Z. Hypoxic induction of vascular endothelial growth factor (VEGF) and angiogenesis in muscle by truncated peroxisome proliferator-activated receptor gamma coactivator (PGC)-1alpha. J. Biol. Chem. 2014;289:8810–8817. doi: 10.1074/jbc.M114.554394. PubMed DOI PMC

Dumesic P.A., Egan D.F., Gut P., Tran M.T., Parisi A., Chatterjee N., Jedrychowski M., Paschini M., Kazak L., Wilensky S.E., et al. An Evolutionarily Conserved uORF Regulates PGC1alpha and Oxidative Metabolism in Mice, Flies, and Bluefin Tuna. Cell Metab. 2019;30:190–200. doi: 10.1016/j.cmet.2019.04.013. PubMed DOI PMC

Liu E.Y., Cali C.P., Lee E.B. RNA metabolism in neurodegenerative disease. Dis. Model. Mech. 2017;10:509–518. doi: 10.1242/dmm.028613. PubMed DOI PMC

Scheckel C., Drapeau E., Frias M.A., Park C.Y., Fak J., Zucker-Scharff I., Kou Y., Haroutunian V., Ma’ayan A., Buxbaum J.D., et al. Regulatory consequences of neuronal ELAV-like protein binding to coding and non-coding RNAs in human brain. Elife. 2016;5:e10421. doi: 10.7554/eLife.10421. PubMed DOI PMC

Puigserver P., Wu Z., Park C.W., Graves R., Wright M., Spiegelman B.M. A cold-inducible coactivator of nuclear receptors linked to adaptive thermogenesis. Cell. 1998;92:829–839. doi: 10.1016/S0092-8674(00)81410-5. PubMed DOI

Shen H., Kan J.L., Green M.R. Arginine-serine-rich domains bound at splicing enhancers contact the branchpoint to promote prespliceosome assembly. Mol. Cell. 2004;13:367–376. doi: 10.1016/S1097-2765(04)00025-5. PubMed DOI

Maris C., Dominguez C., Allain F.H. The RNA recognition motif, a plastic RNA-binding platform to regulate post-transcriptional gene expression. FEBS J. 2005;272:2118–2131. doi: 10.1111/j.1742-4658.2005.04653.x. PubMed DOI

Thijssen-Timmer D.C., Schiphorst M.P., Kwakkel J., Emter R., Kralli A., Wiersinga W.M., Bakker O. PGC-1alpha regulates the isoform mRNA ratio of the alternatively spliced thyroid hormone receptor alpha transcript. J. Mol. Endocrinol. 2006;37:251–257. doi: 10.1677/jme.1.01914. PubMed DOI

Auboeuf D., Honig A., Berget S.M., O’Malley B.W. Coordinate regulation of transcription and splicing by steroid receptor coregulators. Science. 2002;298:416–419. doi: 10.1126/science.1073734. PubMed DOI

Proudfoot N.J., Furger A., Dye M.J. Integrating mRNA processing with transcription. Cell. 2002;108:501–512. doi: 10.1016/S0092-8674(02)00617-7. PubMed DOI

Kornblihtt A.R., Schor I.E., Allo M., Dujardin G., Petrillo E., Munoz M.J. Alternative splicing: A pivotal step between eukaryotic transcription and translation. Nat. Rev. Mol. Cell Biol. 2013;14:153–165. doi: 10.1038/nrm3525. PubMed DOI

Auboeuf D., Dowhan D.H., Kang Y.K., Larkin K., Lee J.W., Berget S.M., O’Malley B.W. Differential recruitment of nuclear receptor coactivators may determine alternative RNA splice site choice in target genes. Proc. Natl. Acad. Sci. USA. 2004;101:2270–2274. doi: 10.1073/pnas.0308133100. PubMed DOI PMC

Reyes A., Anders S., Weatheritt R.J., Gibson T.J., Steinmetz L.M., Huber W. Drift and conservation of differential exon usage across tissues in primate species. Proc. Natl. Acad. Sci. USA. 2013;110:15377–15382. doi: 10.1073/pnas.1307202110. PubMed DOI PMC

Leavitt B.R., Kordasiewicz H.B., Schobel S.A. Huntingtin-Lowering Therapies for Huntington Disease: A Review of the Evidence of Potential Benefits and Risks. JAMA Neurol. 2020;77:764–772. doi: 10.1001/jamaneurol.2020.0299. PubMed DOI

Saudou F., Humbert S. The Biology of Huntingtin. Neuron. 2016;89:910–926. doi: 10.1016/j.neuron.2016.02.003. PubMed DOI

Bruyere J., Abada Y.S., Vitet H., Fontaine G., Deloulme J.C., Ces A., Denarier E., Pernet-Gallay K., Andrieux A., Humbert S., et al. Presynaptic APP levels and synaptic homeostasis are regulated by Akt phosphorylation of huntingtin. Elife. 2020;9 doi: 10.7554/eLife.56371. PubMed DOI PMC

Da C.S., Parone P.A., Lopes V.S., Lillo C., McAlonis-Downes M., Lee S.K., Vetto A.P., Petrosyan S., Marsala M., Murphy A.N., et al. Elevated PGC-1alpha activity sustains mitochondrial biogenesis and muscle function without extending survival in a mouse model of inherited ALS. Cell Metab. 2012;15:778–786. PubMed PMC

Liang H., Ward W.F., Jang Y.C., Bhattacharya A., Bokov A.F., Li Y., Jernigan A., Richardson A., Van Remmen H. PGC-1alpha protects neurons and alters disease progression in an amyotrophic lateral sclerosis mouse model. Muscle Nerve. 2011;44:947–956. doi: 10.1002/mus.22217. PubMed DOI

Liao Y.C., Fernandopulle M.S., Wang G., Choi H., Hao L., Drerup C.M., Patel R., Qamar S., Nixon-Abell J., Shen Y., et al. RNA Granules Hitchhike on Lysosomes for Long-Distance Transport, Using Annexin A11 as a Molecular Tether. Cell. 2019;179:147–164. doi: 10.1016/j.cell.2019.08.050. PubMed DOI PMC

Smith B.N., Topp S.D., Fallini C., Shibata H., Chen H.J., Troakes C., King A., Ticozzi N., Kenna K.P., Soragia-Gkazi A., et al. Mutations in the vesicular trafficking protein annexin A11 are associated with amyotrophic lateral sclerosis. Sci. Transl. Med. 2017;9:eaad9157. doi: 10.1126/scitranslmed.aad9157. PubMed DOI PMC

Zhang K., Liu Q., Liu K., Shen D., Tai H., Shu S., Ding Q., Fu H., Liu S., Wang Z., et al. ANXA11 mutations prevail in Chinese ALS patients with and without cognitive dementia. Neurol. Genet. 2018;4:e237. doi: 10.1212/NXG.0000000000000237. PubMed DOI PMC

Giordana M.T., Piccinini M., Grifoni S., De M.G., Vercellino M., Magistrello M., Pellerino A., Buccinna B., Lupino E., Rinaudo M.T. TDP-43 redistribution is an early event in sporadic amyotrophic lateral sclerosis. Brain Pathol. 2010;20:351–360. doi: 10.1111/j.1750-3639.2009.00284.x. PubMed DOI PMC

Schipper L.J., Raaphorst J., Aronica E., Baas F., de Haan R., de Visser M., Troost D. Prevalence of brain and spinal cord inclusions, including dipeptide repeat proteins, in patients with the C9ORF72 hexanucleotide repeat expansion: A systematic neuropathological review. Neuropathol. Appl. Neurobiol. 2016;42:547–560. doi: 10.1111/nan.12284. PubMed DOI

Braak H., Brettschneider J., Ludolph A.C., Lee V.M., Trojanowski J.Q., del Tredici K. Amyotrophic lateral sclerosis--a model of corticofugal axonal spread. Nat. Rev. Neurol. 2013;9:708–714. doi: 10.1038/nrneurol.2013.221. PubMed DOI PMC

Melamed Z., Lopez-Erauskin J., Baughn M.W., Zhang O., Drenner K., Sun Y., Freyermuth F., McMahon M.A., Beccari M.S., Artates J.W., et al. Premature polyadenylation-mediated loss of stathmin-2 is a hallmark of TDP-43-dependent neurodegeneration. Nat. Neurosci. 2019;22:180–190. doi: 10.1038/s41593-018-0293-z. PubMed DOI PMC

Wang Q., Zhang Y., Wang M., Song W.M., Shen Q., McKenzie A., Zhou X., Pan P.Y., Yue Z., Zhang B. The landscape of multiscale transcriptomic networks and key regulators in Parkinson’s disease. Nat. Commun. 2019;10:5234. doi: 10.1038/s41467-019-13144-y. PubMed DOI PMC

Lesnick T.G., Papapetropoulos S., Mash D.C., Ffrench-Mullen J., Shehadeh L., de Andrade M., Henley J.R., Rocca W.A., Ahlskog J.E., Maraganore D.M. A genomic pathway approach to a complex disease: Axon guidance and Parkinson disease. PLoS Genet. 2007;3:e98. doi: 10.1371/journal.pgen.0030098. PubMed DOI PMC

Area-Gomez E., Guardia-Laguarta C., Schon E.A., Przedborski S. Mitochondria, OxPhos, and neurodegeneration: Cells are not just running out of gas. J. Clin. Investig. 2019;129:34–45. doi: 10.1172/JCI120848. PubMed DOI PMC

Vaarmann A., Mandel M., Zeb A., Wareski P., Liiv J., Kuum M., Antsov E., Liiv M., Cagalinec M., Choubey V., et al. Mitochondrial biogenesis is required for axonal growth. Development. 2016;143:1981–1992. doi: 10.1242/dev.128926. PubMed DOI

Billingsley K.J., Barbosa I.A., Bandres-Ciga S., Quinn J.P., Bubb V.J., Deshpande C., Botia J.A., Reynolds R.H., Zhang D., Simpson M.A., et al. Mitochondria function associated genes contribute to Parkinson’s Disease risk and later age at onset. NPJ Parkinsons. Dis. 2019;5:8. doi: 10.1038/s41531-019-0080-x. PubMed DOI PMC

Li Q.S., Parrado A.R., Samtani M.N., Narayan V.A. Variations in the FRA10AC1 Fragile Site and 15q21 Are Associated with Cerebrospinal Fluid Abeta1-42 Level. PLoS ONE. 2015;10:e0134000. PubMed PMC

Goes F.S., McGrath J., Avramopoulos D., Wolyniec P., Pirooznia M., Ruczinski I., Nestadt G., Kenny E.E., Vacic V., Peters I., et al. Genome-wide association study of schizophrenia in Ashkenazi Jews. Am. J. Med. Genet. B Neuropsychiatr. Genet. 2015;168:649–659. doi: 10.1002/ajmg.b.32349. PubMed DOI

Muller S.H., Girard S.L., Hopfner F., Merner N.D., Bourassa C.V., Lorenz D., Clark L.N., Tittmann L., Soto-Ortolaza A.I., Klebe S., et al. Genome-wide association study in essential tremor identifies three new loci. Brain. 2016;139:3163–3169. doi: 10.1093/brain/aww242. PubMed DOI PMC

Dong J., Yang J., Tranah G., Franceschini N., Parimi N., Alkorta-Aranburu G., Xu Z., Alonso A., Cummings S.R., Fornage M., et al. Genome-wide Meta-analysis on the Sense of Smell Among US Older Adults. Medicine. 2015;94:e1892. doi: 10.1097/MD.0000000000001892. PubMed DOI PMC

Zhou M., Melin M.D., Xu W., Sudhof T.C. Dysfunction of parvalbumin neurons in the cerebellar nuclei produces an action tremor. J. Clin. Investig. 2020;130:5142–5156. doi: 10.1172/JCI135802. PubMed DOI PMC

Lucas E.K., Dougherty S.E., McMeekin L.J., Reid C.S., Dobrunz L.E., West A.B., Hablitz J.J., Cowell R.M. PGC-1alpha provides a transcriptional framework for synchronous neurotransmitter release from parvalbumin-positive interneurons. J. Neurosci. 2014;34:14375–14387. doi: 10.1523/JNEUROSCI.1222-14.2014. PubMed DOI PMC

Kent W.J., Sugnet C.W., Furey T.S., Roskin K.M., Pringle T.H., Zahler A.M., Haussler D. The human genome browser at UCSC. Genome Res. 2002;12:996–1006. doi: 10.1101/gr.229102. PubMed DOI PMC

Hsu P.D., Scott D.A., Weinstein J.A., Ran F.A., Konermann S., Agarwala V., Li Y., Fine E.J., Wu X., Shalem O., et al. DNA targeting specificity of RNA-guided Cas9 nucleases. Nat. Biotechnol. 2013;31:827–832. doi: 10.1038/nbt.2647. PubMed DOI PMC

Doench J.G., Hartenian E., Graham D.B., Tothova Z., Hegde M., Smith I., Sullender M., Ebert B.L., Xavier R.J., Root D.E. Rational design of highly active sgRNAs for CRISPR-Cas9-mediated gene inactivation. Nat. Biotechnol. 2014;32:1262–1267. doi: 10.1038/nbt.3026. PubMed DOI PMC

Haeussler M., Schonig K., Eckert H., Eschstruth A., Mianne J., Renaud J.B., Schneider-Maunoury S., Shkumatava A., Teboul L., Kent J., et al. Evaluation of off-target and on-target scoring algorithms and integration into the guide RNA selection tool CRISPOR. Genome Biol. 2016;17:148. doi: 10.1186/s13059-016-1012-2. PubMed DOI PMC

Alkan F., Wenzel A., Anthon C., Havgaard J.H., Gorodkin J. CRISPR-Cas9 off-targeting assessment with nucleic acid duplex energy parameters. Genome Biol. 2018;19:177. doi: 10.1186/s13059-018-1534-x. PubMed DOI PMC

Auer S., Hahne P., Soyal S.M., Felder T., Miller K., Paulmichl M., Krempler F., Oberkofler H., Patsch W. Potential role of upstream stimulatory factor 1 gene variant in familial combined hyperlipidemia and related disorders. Arter. Thromb. Vasc. Biol. 2012;32:1535–1544. doi: 10.1161/ATVBAHA.112.245639. PubMed DOI

Bolger A.M., Lohse M., Usadel B. Trimmomatic: A flexible trimmer for Illumina sequence data. Bioinformatics. 2014;30:2114–2120. doi: 10.1093/bioinformatics/btu170. PubMed DOI PMC

Dobin A., Davis C.A., Schlesinger F., Drenkow J., Zaleski C., Jha S., Batut P., Chaisson M., Gingeras T.R. STAR: Ultrafast universal RNA-seq aligner. Bioinformatics. 2013;29:15–21. doi: 10.1093/bioinformatics/bts635. PubMed DOI PMC

National Center for Biotechnology Information, NIH. [(accessed on 16 March 2020)]; Available online: www.ncbi.nlm.nih.gov.

e!Ensembl. [(accessed on 16 March 2020)]; Available online: http://www.ensembl.org.

Li H., Handsaker B., Wysoker A., Fennell T., Ruan J., Homer N., Marth G., Abecasis G., Durbin R. The Sequence Alignment/Map format and SAMtools. Bioinformatics. 2009;25:2078–2079. doi: 10.1093/bioinformatics/btp352. PubMed DOI PMC

Li B., Dewey C.N. RSEM: Accurate transcript quantification from RNA-Seq data with or without a reference genome. BMC Bioinform. 2011;12:323. doi: 10.1186/1471-2105-12-323. PubMed DOI PMC

Robinson M.D., McCarthy D.J., Smyth G.K. edgeR: A Bioconductor package for differential expression analysis of digital gene expression data. Bioinformatics. 2010;26:139–140. doi: 10.1093/bioinformatics/btp616. PubMed DOI PMC

Huber W., Carey V.J., Gentleman R., Anders S., Carlson M., Carvalho B.S., Bravo H.C., Davis S., Gatto L., Girke T., et al. Orchestrating high-throughput genomic analysis with Bioconductor. Nat. Methods. 2015;12:115–121. doi: 10.1038/nmeth.3252. PubMed DOI PMC

McCarthy D.J., Chen Y., Smyth G.K. Differential expression analysis of multifactor RNA-Seq experiments with respect to biological variation. Nucleic Acids Res. 2012;40:4288–4297. doi: 10.1093/nar/gks042. PubMed DOI PMC

Hochberg Y., Benjamini Y. More powerful procedures for multiple significance testing. Stat. Med. 1990;9:811–818. doi: 10.1002/sim.4780090710. PubMed DOI

Wickham H. Ggplot: Elegant Graphics for Data Analysis. Springer; New York, NY, USA: 2016.

Cran.r-project org/index. [(accessed on 16 March 2020)]; Available online: https://CRAN.R-project.org/index/htlm.

Liao Y., Smyth G.K., Shi W. featureCounts: An efficient general purpose program for assigning sequence reads to genomic features. Bioinformatics. 2014;30:923–930. doi: 10.1093/bioinformatics/btt656. PubMed DOI

Katz Y., Wang E.T., Silterra J., Schwartz S., Wong B., Thorvaldsdottir H., Robinson J.T., Mesirov J.P., Airoldi E.M., Burge C.B. Quantitative visualization of alternative exon expression from RNA-seq data. Bioinformatics. 2015;31:2400–2402. doi: 10.1093/bioinformatics/btv034. PubMed DOI PMC

Katz Y., Wang E.T., Airoldi E.M., Burge C.B. Analysis and design of RNA sequencing experiments for identifying isoform regulation. Nat. Methods. 2010;7:1009–1015. doi: 10.1038/nmeth.1528. PubMed DOI PMC

Hahne F., Ivanek R. Visualizing Genomic Data Using Gviz and Bioconductor. Methods Mol. Biol. 2016;1418:335–351. PubMed

Kramer A., Green J., Pollard J., Jr., Tugendreich S. Causal analysis approaches in Ingenuity Pathway Analysis. Bioinformatics. 2014;30:523–530. doi: 10.1093/bioinformatics/btt703. PubMed DOI PMC

Calvo S.E., Clauser K.R., Mootha V.K. MitoCarta2.0: An updated inventory of mammalian mitochondrial proteins. Nucleic Acids Res. 2016;44:D1251–D1257. doi: 10.1093/nar/gkv1003. PubMed DOI PMC

Ashburner M., Ball C.A., Blake J.A., Botstein D., Butler H., Cherry J.M., Davis A.P., Dolinski K., Dwight S.S., Eppig J.T., et al. Gene ontology: Tool for the unification of biology. The Gene Ontology Consortium. Nat. Genet. 2000;25:25–29. doi: 10.1038/75556. PubMed DOI PMC

The Gene Ontology Consortium The Gene Ontology Resource: 20 years and still GOing strong. Nucleic Acids Res. 2019;47:D330–D338. doi: 10.1093/nar/gky1055. PubMed DOI PMC